As West Pharmaceuticals Services (WST) Share Value Rose, Kalmar Investments INC Has Cut by $7.69 Million Its Holding

June 20, 2017 - By Ellis Scott

Investors sentiment decreased to 0.96 in Q4 2016. Its down 0.05, from 1.01 in 2016Q3. It fall, as 31 investors sold WST shares while 97 reduced holdings. 45 funds opened positions while 78 raised stakes. 66.40 million shares or 1.35% more from 65.52 million shares in 2016Q3 were reported. Fred Alger Incorporated has invested 0% in West Pharmaceutical Services Inc. (NYSE:WST). Century Inc has 701,075 shares. Bridgecreek Limited reported 3,000 shares. Mount Lucas Management Ltd Partnership has invested 0.05% in West Pharmaceutical Services Inc. (NYSE:WST). Ubs Asset Mgmt Americas holds 0.01% or 98,008 shares in its portfolio. 747,341 were reported by Retail Bank Of America De. Bokf Na has invested 0.01% in West Pharmaceutical Services Inc. (NYSE:WST). Kalmar De holds 695,976 shares or 3.04% of its portfolio. Loomis Sayles And Limited Partnership holds 67,096 shares. M&T Fincl Bank owns 64,658 shares for 0.03% of their portfolio. Calvert Investment Management Inc invested in 0.01% or 4,697 shares. California Employees Retirement Sys accumulated 178,700 shares or 0.03% of the stock. Bank has 0.02% invested in West Pharmaceutical Services Inc. (NYSE:WST). State Of Wisconsin Inv Board has invested 0.01% of its portfolio in West Pharmaceutical Services Inc. (NYSE:WST). Ngam Advsrs Limited Partnership stated it has 10,731 shares.

Since May 2, 2017, it had 0 insider buys, and 2 sales for $5.63 million activity. $384,816 worth of West Pharmaceutical Services Inc. (NYSE:WST) was sold by Malone Daniel on Tuesday, May 2. FEDERICI WILLIAM J also sold $5.25M worth of West Pharmaceutical Services Inc. (NYSE:WST) shares.

Kalmar Investments Inc decreased its stake in West Pharmaceuticals Services (WST) by 11.62% based on its latest 2016Q4 regulatory filing with the SEC. Kalmar Investments Inc sold 91,529 shares as the company’s stock rose 14.65% with the market. The institutional investor held 695,976 shares of the basic industries company at the end of 2016Q4, valued at $59.04 million, down from 787,505 at the end of the previous reported quarter. Kalmar Investments Inc who had been investing in West Pharmaceuticals Services for a number of months, seems to be less bullish one the $7.11B market cap company. The stock increased 1.05% or $1.01 during the last trading session, reaching $96.98. About shares traded. West Pharmaceutical Services Inc. (NYSE:WST) has risen 33.75% since June 20, 2016 and is uptrending. It has outperformed by 17.05% the S&P500.

Kalmar Investments Inc, which manages about $1.25 billion and $1.95B US Long portfolio, upped its stake in Kar Auction Services Inc (NYSE:KAR) by 123,020 shares to 512,015 shares, valued at $21.82M in 2016Q4, according to the filing. It also increased its holding in Imax Corp (NYSE:IMAX) by 197,410 shares in the quarter, for a total of 795,010 shares, and has risen its stake in Popeyes Louisiana Kitchen Inc (NASDAQ:PLKI).

Analysts expect West Pharmaceutical Services Inc. (NYSE:WST) to report $0.65 EPS on July, 27.They anticipate $0.06 EPS change or 10.17 % from last quarter’s $0.59 EPS. WST’s profit would be $47.65 million giving it 37.30 P/E if the $0.65 EPS is correct. After having $0.60 EPS previously, West Pharmaceutical Services Inc.’s analysts see 8.33 % EPS growth.

More notable recent West Pharmaceutical Services Inc. (NYSE:WST) news were published by: Seekingalpha.com which released: “The Expectations For West Pharmaceutical Look Hard To Meet” on March 17, 2017, also Prnewswire.com with their article: “West Pharmaceutical Services’ Karen Flynn Receives Silver StevieĀ® Award in …” published on December 20, 2016, Nasdaq.com published: “West Pharmaceutical Services, Inc. (WST) Ex-Dividend Date Scheduled for April …” on April 13, 2017. More interesting news about West Pharmaceutical Services Inc. (NYSE:WST) were released by: Prnewswire.com and their article: “West Announces Quarterly Dividend and Participation in Upcoming Investor …” published on May 15, 2017 as well as Fool.com‘s news article titled: “Why West Pharmaceutical Services Is Rising Today” with publication date: April 27, 2017.

West Pharmaceutical Services Inc. (NYSE:WST) Ratings Coverage

Among 2 analysts covering West Pharmaceutical Services (NYSE:WST), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. West Pharmaceutical Services had 5 analyst reports since August 4, 2015 according to SRatingsIntel. On Tuesday, August 4 the stock rating was downgraded by Zacks to “Hold”. The rating was downgraded by Wells Fargo to “Market Perform” on Wednesday, September 21. The rating was upgraded by Wells Fargo on Friday, October 28 to “Outperform”. The firm has “Buy” rating given on Friday, January 8 by Janney Capital. Wells Fargo initiated West Pharmaceutical Services Inc. (NYSE:WST) on Tuesday, March 22 with “Outperform” rating.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.